BCG (Bacillus of Calmette Guerin) therapy of high-risk superficial bladder cancer
- 4 March 2002
- journal article
- review article
- Published by Elsevier in Surgical Oncology
- Vol. 11 (1-2) , 77-83
- https://doi.org/10.1016/s0960-7404(02)00008-7
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Low Dose Pasteur Bacillus Calmette-Guerin Regimen in Stage T1, Grade 3 Bladder Cancer TherapyJournal of Urology, 1996
- A Randomized Prospective Study Comparing Long-Term Intravesical Instillations of Mitomycin C and Bacillus Calmette-Guerin in Patients with Superficial Bladder CarcinomaJournal of Urology, 1996
- In situ transitional cell carcinoma involvement of prostatic urethra: Bacillus calmette-guérin therapy without previous transurethral resection of the prostateUrology, 1996
- Intravesical Bacillus Calmette-Guerin for Treatment of Superficial Transitional Cell Carcinoma of the Prostatic Urethra in Association With Carcinoma of the BladderJournal of Urology, 1995
- Intravesical Bacillus Calmette‐Guérin with the Danish Strain for Treatment of Carcinoma In situ of the BladderBritish Journal of Urology, 1993
- A Randomized Trial of Intravesical Doxorubicin and Immunotherapy with Bacille Calmette–Guérin for Transitional-Cell Carcinoma of the BladderNew England Journal of Medicine, 1991
- Intravesical Bacillus Calmette-Guerin Therapy for in situ Transitional Cell Carcinoma Involving the Prostatic UrethraJournal of Urology, 1989
- Transitional cell carcinoma of the prostate: Diagnosis, staging and managementWorld Journal of Urology, 1988
- Superficial Transitional Cell Carcinoma of the Bladder Associated with Mucosal Involvement of the Prostatic Urethra: Results of Treatment with Intravesical Bacillus Calmette-GuerinJournal of Urology, 1988
- Long-Term Effect of Intravesical Bacillus Calmette-Guerin on Flat Carcinoma in Situ of the BladderJournal of Urology, 1986